Quantcast

Latest glioblastoma multiforme Stories

2015-03-09 16:33:58

ICT-107 Poised to Begin Phase 3 Registration Trial in Second Half of 2015; Business Update Conference Call to be Held on March 12, 2015 LOS ANGELES, March 9, 2015 /PRNewswire/ -- ImmunoCellular

2015-03-04 08:29:57

-- Potent killing of highly resistant adult and pediatric brain cancer cells SYDNEY, March 4, 2015 /PRNewswire/ -- Australian/US biotechnology company, Novogen Limited (ASX:NRT; NASDAQ:NVGN),

2015-03-03 08:35:41

- Live Presentation with Audio Webcast on Tuesday, March 10th at 5:00 p.m. Pacific Time / 8:00 p.m.

2015-03-02 12:31:21

VANCOUVER, British Columbia and MENLO PARK, Calif., March 2, 2015 /PRNewswire/ -- DelMar Pharmaceuticals,

GettyImages_462557727
2015-02-28 10:48:28

Cancer research has truly gone to the dogs as scientists at the University of Illinois have announced the start of phase I trials for a drug showed good results in the treatment of spontaneously occurring cancers in pet dogs.

2015-02-25 08:32:44

Industry and Academic Leader Co-Founded Several Successful Biotechnology Companies, Including Alnylam, Cubist and Alkermes SAN DIEGO, Feb.

2015-02-24 08:35:01

- Updated Phase I/II clinical trial data on the maximum tolerated dose for VAL-083 in the treatment of glioblastoma multiforme (GBM) to be presented - VANCOUVER, British Columbia

2015-02-19 16:30:23

NEW YORK, Feb. 19, 2015 /PRNewswire/ -- Novogen presented yesterday (Wednesday February 18) to an audience of stockholders, analysts, investors and investment bankers.

2015-02-19 12:28:28

BETHESDA, Md., Feb. 19, 2015 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.


Word of the Day
chomage
  • Stoppage; cessation (of labor).
  • A standing still or idling (of mills, factories, etc.).
The word chomage comes into English from French.]
Related